ReviewJournal of extracellular vesicles2020

COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?

Philip W AskenasePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.